Why the study?
Does miniaturized extracorporeal circulation improve clinical and non-clinical outcomes compared to off-pump coronary artery surgery in patients undergoing coronary artery bypass grafting?
Does miniaturized extracorporeal circulation improve clinical and non-clinical outcomes compared to off-pump coronary artery surgery in patients undergoing coronary artery bypass grafting?
This review outlines the proposed benefits and pitfalls of miniaturized extracorporeal circulation compared to off-pump coronary artery surgery for revascularization.
Answers are grounded in this paper and cite their sources.
Proposed benefits and pitfalls of miniaturized extracorporeal circulation versus off-pump CABG lack supporting data; leaves open need for randomized trials.
Recognition of the potentially deleterious effects of esxtracorporeal circulation led to off-pump coronary artery surgery (OPCAB) experiencing a surge in popularity in the initial decade after its conception. However, OPCAB has its own limitations and technical difficulties, such as coronary access, increased left ventricular size and reduced function, which may lead to the potential for suboptimal revascularization. As an alternative technique, miniaturized extracorporeal circulation (mECC) may provide a more controlled operative field in which the heart may be manipulated whilst minimizing the inflammatory, coagulopathic and haemodilutional effects of cardiopulmonary bypass. In this review, we outline the proposed benefits of the mECC system, discuss the pitfalls associated with mECC, and directly compare mECC to 'off-pump' coronary surgery for a variety of clinical and non-clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Harling et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: